RNS
NVO

Robert N. Shapiro’s Novo Nordisk NVO Stock Holding History

Robert N. Shapiro’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$435K Buy
20,598
+1,750
+9% +$39.1K 0.09% 195
2014
Q3 		$448K Buy
18,848
+54
+0.3% +$1.24K 0.09% 191
2014
Q2 		$435K Buy
18,794
+1,500
+9% +$33.1K 0.08% 194
2014
Q1 		$395K Buy
17,294
+64
+0.4% +$1.36K 0.07% 195
2013
Q4 		$318K Hold
17,230
– – 0.06% 219
2013
Q3 		$292K Hold
17,230
– – 0.05% 224
2013
Q2 		$267K Buy
+17,230
New +$287K 0.06% 228

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Robert N. Shapiro's NVO Position: Q4 2014 in Review

Robert N. Shapiro increased its Novo Nordisk (NVO) stake by 9.3% in Q4 2014, buying an estimated $39.1K and bringing the position to 20,598 shares worth $435K. The position accounts for 0.09% of the portfolio, ranked #195.

Robert N. Shapiro first reported a position in NVO in Q2 2013 and has held it in 7 quarters since. The position peaked at $448K in Q3 2014. 500 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

  • Robert N. Shapiro held 20,598 shares of Novo Nordisk worth $435K as of Q4 2014.
  • Robert N. Shapiro bought 1,750 Novo Nordisk shares in Q4 2014, an estimated $39.1K.
  • Novo Nordisk made up 0.09% of Robert N. Shapiro's portfolio in Q4 2014, its #195 holding.
  • Robert N. Shapiro first reported a position in Novo Nordisk in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's Novo Nordisk position peaked at $448K in Q3 2014.
  • 500 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.